nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2E1—prostate cancer	0.137	0.502	CbGaD
Thioridazine—CYP2C19—prostate cancer	0.136	0.498	CbGaD
Thioridazine—CYP2C8—Nilutamide—prostate cancer	0.031	0.074	CbGbCtD
Thioridazine—CYP2C19—Bicalutamide—prostate cancer	0.026	0.0621	CbGbCtD
Thioridazine—CYP2C19—Nilutamide—prostate cancer	0.026	0.0621	CbGbCtD
Thioridazine—CYP2C8—Abiraterone—prostate cancer	0.0257	0.0613	CbGbCtD
Thioridazine—CYP2E1—Estrone—prostate cancer	0.0249	0.0593	CbGbCtD
Thioridazine—CYP2C9—Nilutamide—prostate cancer	0.0216	0.0516	CbGbCtD
Thioridazine—CYP2C9—Bicalutamide—prostate cancer	0.0216	0.0516	CbGbCtD
Thioridazine—CYP2C19—Flutamide—prostate cancer	0.0216	0.0514	CbGbCtD
Thioridazine—CYP1A2—Flutamide—prostate cancer	0.0199	0.0475	CbGbCtD
Thioridazine—CYP2D6—Bicalutamide—prostate cancer	0.0198	0.0472	CbGbCtD
Thioridazine—CYP2C8—Cabazitaxel—prostate cancer	0.019	0.0454	CbGbCtD
Thioridazine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0166	0.0395	CbGbCtD
Thioridazine—CYP2D6—Abiraterone—prostate cancer	0.0164	0.0391	CbGbCtD
Thioridazine—ADRA1B—vas deferens—prostate cancer	0.0163	0.294	CbGeAlD
Thioridazine—CYP2E1—Mitoxantrone—prostate cancer	0.0148	0.0353	CbGbCtD
Thioridazine—CYP1A2—Estrone—prostate cancer	0.0144	0.0343	CbGbCtD
Thioridazine—CYP2C9—Estrone—prostate cancer	0.013	0.0309	CbGbCtD
Thioridazine—CYP2C8—Estradiol—prostate cancer	0.0107	0.0255	CbGbCtD
Thioridazine—CYP2C9—Capecitabine—prostate cancer	0.00982	0.0234	CbGbCtD
Thioridazine—HTR7—vas deferens—prostate cancer	0.00947	0.171	CbGeAlD
Thioridazine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00941	0.0224	CbGbCtD
Thioridazine—CYP2E1—Etoposide—prostate cancer	0.00932	0.0223	CbGbCtD
Thioridazine—CYP2C19—Estradiol—prostate cancer	0.00895	0.0214	CbGbCtD
Thioridazine—CYP1A2—Estradiol—prostate cancer	0.00826	0.0197	CbGbCtD
Thioridazine—CYP2C19—Prednisone—prostate cancer	0.0077	0.0184	CbGbCtD
Thioridazine—CYP2C9—Estradiol—prostate cancer	0.00744	0.0178	CbGbCtD
Thioridazine—CYP2C8—Etoposide—prostate cancer	0.00697	0.0166	CbGbCtD
Thioridazine—CYP1A2—Etoposide—prostate cancer	0.00539	0.0129	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—prostate cancer	0.00303	0.00723	CbGbCtD
Thioridazine—CYP2C19—urine—prostate cancer	0.0023	0.0416	CbGeAlD
Thioridazine—CYP1A2—urine—prostate cancer	0.00188	0.034	CbGeAlD
Thioridazine—CYP2C9—urine—prostate cancer	0.00178	0.0322	CbGeAlD
Thioridazine—CYP2E1—urine—prostate cancer	0.00169	0.0306	CbGeAlD
Thioridazine—HTR2A—urine—prostate cancer	0.00147	0.0266	CbGeAlD
Thioridazine—CYP2D6—urine—prostate cancer	0.00134	0.0242	CbGeAlD
Thioridazine—CHRM2—prostate gland—prostate cancer	0.00109	0.0197	CbGeAlD
Thioridazine—ADRA1B—renal system—prostate cancer	0.00099	0.0179	CbGeAlD
Thioridazine—ADRA1A—prostate gland—prostate cancer	0.000816	0.0147	CbGeAlD
Thioridazine—KCNH2—prostate gland—prostate cancer	0.000788	0.0142	CbGeAlD
Thioridazine—KCNH2—seminal vesicle—prostate cancer	0.000666	0.012	CbGeAlD
Thioridazine—HRH1—prostate gland—prostate cancer	0.000632	0.0114	CbGeAlD
Thioridazine—HTR7—epithelium—prostate cancer	0.000622	0.0112	CbGeAlD
Thioridazine—ADRA2A—prostate gland—prostate cancer	0.00062	0.0112	CbGeAlD
Thioridazine—CYP2E1—prostate gland—prostate cancer	0.000607	0.011	CbGeAlD
Thioridazine—HTR1A—renal system—prostate cancer	0.000603	0.0109	CbGeAlD
Thioridazine—ADRA1A—epithelium—prostate cancer	0.0006	0.0108	CbGeAlD
Thioridazine—HTR7—renal system—prostate cancer	0.000577	0.0104	CbGeAlD
Thioridazine—ADRA1A—renal system—prostate cancer	0.000556	0.0101	CbGeAlD
Thioridazine—KCNH2—renal system—prostate cancer	0.000537	0.00971	CbGeAlD
Thioridazine—KCNH2—urethra—prostate cancer	0.000528	0.00954	CbGeAlD
Thioridazine—ADRA2A—seminal vesicle—prostate cancer	0.000525	0.00948	CbGeAlD
Thioridazine—CYP2E1—seminal vesicle—prostate cancer	0.000513	0.00928	CbGeAlD
Thioridazine—CYP2C8—renal system—prostate cancer	0.000491	0.00888	CbGeAlD
Thioridazine—HRH1—epithelium—prostate cancer	0.000464	0.00839	CbGeAlD
Thioridazine—CYP1A2—renal system—prostate cancer	0.00046	0.00831	CbGeAlD
Thioridazine—HRH1—urethra—prostate cancer	0.000423	0.00764	CbGeAlD
Thioridazine—ADRA2A—urethra—prostate cancer	0.000415	0.00751	CbGeAlD
Thioridazine—CYP2E1—renal system—prostate cancer	0.000414	0.00748	CbGeAlD
Thioridazine—CYP2E1—urethra—prostate cancer	0.000406	0.00734	CbGeAlD
Thioridazine—KCNH2—bone marrow—prostate cancer	0.000406	0.00734	CbGeAlD
Thioridazine—HTR2A—epithelium—prostate cancer	0.000388	0.00701	CbGeAlD
Thioridazine—HTR7—testis—prostate cancer	0.000373	0.00673	CbGeAlD
Thioridazine—HTR2A—renal system—prostate cancer	0.00036	0.0065	CbGeAlD
Thioridazine—DRD2—testis—prostate cancer	0.000352	0.00637	CbGeAlD
Thioridazine—KCNH2—testis—prostate cancer	0.000347	0.00627	CbGeAlD
Thioridazine—CYP2D6—renal system—prostate cancer	0.000328	0.00592	CbGeAlD
Thioridazine—CYP2C8—testis—prostate cancer	0.000318	0.00574	CbGeAlD
Thioridazine—Perphenazine—AOX1—prostate cancer	0.000291	0.11	CrCbGaD
Thioridazine—HRH1—testis—prostate cancer	0.000278	0.00503	CbGeAlD
Thioridazine—ADRA2A—testis—prostate cancer	0.000273	0.00494	CbGeAlD
Thioridazine—CYP2E1—testis—prostate cancer	0.000267	0.00483	CbGeAlD
Thioridazine—KCNH2—lymph node—prostate cancer	0.000252	0.00455	CbGeAlD
Thioridazine—HTR2A—testis—prostate cancer	0.000232	0.0042	CbGeAlD
Thioridazine—CYP2D6—testis—prostate cancer	0.000212	0.00383	CbGeAlD
Thioridazine—HRH1—lymph node—prostate cancer	0.000202	0.00365	CbGeAlD
Thioridazine—ADRA2A—lymph node—prostate cancer	0.000198	0.00358	CbGeAlD
Thioridazine—Eletriptan—CYP2A6—prostate cancer	0.00018	0.0683	CrCbGaD
Thioridazine—Acepromazine—SLC22A1—prostate cancer	0.000162	0.0613	CrCbGaD
Thioridazine—Thioproperazine—SLC22A1—prostate cancer	0.000158	0.06	CrCbGaD
Thioridazine—Pipotiazine—SLC22A1—prostate cancer	0.000155	0.059	CrCbGaD
Thioridazine—Thiothixene—SLC22A1—prostate cancer	0.000155	0.059	CrCbGaD
Thioridazine—Decreased appetite—Goserelin—prostate cancer	0.00014	0.00103	CcSEcCtD
Thioridazine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000138	0.00102	CcSEcCtD
Thioridazine—Constipation—Goserelin—prostate cancer	0.000137	0.00101	CcSEcCtD
Thioridazine—Nausea—Bicalutamide—prostate cancer	0.000137	0.00101	CcSEcCtD
Thioridazine—Vision blurred—Mitoxantrone—prostate cancer	0.000137	0.00101	CcSEcCtD
Thioridazine—Pancytopenia—Docetaxel—prostate cancer	0.000137	0.00101	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisone—prostate cancer	0.000137	0.00101	CcSEcCtD
Thioridazine—Constipation—Conjugated Estrogens—prostate cancer	0.000136	0.001	CcSEcCtD
Thioridazine—Sweating increased—Capecitabine—prostate cancer	0.000136	0.001	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—prostate cancer	0.000135	0.000991	CcSEcCtD
Thioridazine—Anaemia—Mitoxantrone—prostate cancer	0.000134	0.000988	CcSEcCtD
Thioridazine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000133	0.000982	CcSEcCtD
Thioridazine—Clomipramine—GSTP1—prostate cancer	0.000133	0.0504	CrCbGaD
Thioridazine—Pancytopenia—Capecitabine—prostate cancer	0.000133	0.000975	CcSEcCtD
Thioridazine—Feeling abnormal—Goserelin—prostate cancer	0.000132	0.000973	CcSEcCtD
Thioridazine—Weight increased—Docetaxel—prostate cancer	0.000131	0.000965	CcSEcCtD
Thioridazine—Perphenazine—CYP2C18—prostate cancer	0.00013	0.0494	CrCbGaD
Thioridazine—Leukopenia—Mitoxantrone—prostate cancer	0.00013	0.000957	CcSEcCtD
Thioridazine—Confusional state—Estradiol—prostate cancer	0.000128	0.000944	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—prostate cancer	0.000128	0.000943	CcSEcCtD
Thioridazine—Photosensitivity reaction—Capecitabine—prostate cancer	0.000127	0.000937	CcSEcCtD
Thioridazine—Oedema—Estradiol—prostate cancer	0.000127	0.000936	CcSEcCtD
Thioridazine—Weight increased—Capecitabine—prostate cancer	0.000127	0.000935	CcSEcCtD
Thioridazine—Body temperature increased—Goserelin—prostate cancer	0.000127	0.000934	CcSEcCtD
Thioridazine—Eletriptan—CYP2C19—prostate cancer	0.000127	0.048	CrCbGaD
Thioridazine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000126	0.000925	CcSEcCtD
Thioridazine—Jaundice—Docetaxel—prostate cancer	0.000125	0.000922	CcSEcCtD
Thioridazine—Tachycardia—Estradiol—prostate cancer	0.000124	0.000914	CcSEcCtD
Thioridazine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000124	0.000913	CcSEcCtD
Thioridazine—Hyperhidrosis—Estradiol—prostate cancer	0.000123	0.000905	CcSEcCtD
Thioridazine—Rash—Ethinyl Estradiol—prostate cancer	0.000123	0.000905	CcSEcCtD
Thioridazine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000123	0.000904	CcSEcCtD
Thioridazine—Headache—Ethinyl Estradiol—prostate cancer	0.000122	0.000899	CcSEcCtD
Thioridazine—Jaundice—Capecitabine—prostate cancer	0.000121	0.000892	CcSEcCtD
Thioridazine—Sweating increased—Prednisone—prostate cancer	0.000121	0.000891	CcSEcCtD
Thioridazine—Agranulocytosis—Docetaxel—prostate cancer	0.00012	0.000883	CcSEcCtD
Thioridazine—Confusional state—Mitoxantrone—prostate cancer	0.00012	0.00088	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000119	0.000877	CcSEcCtD
Thioridazine—Clemastine—CYP3A4—prostate cancer	0.000119	0.0452	CrCbGaD
Thioridazine—Oedema—Mitoxantrone—prostate cancer	0.000119	0.000873	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—prostate cancer	0.000119	0.000872	CcSEcCtD
Thioridazine—Hypersensitivity—Goserelin—prostate cancer	0.000118	0.00087	CcSEcCtD
Thioridazine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000117	0.000862	CcSEcCtD
Thioridazine—Agranulocytosis—Capecitabine—prostate cancer	0.000116	0.000854	CcSEcCtD
Thioridazine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000116	0.000854	CcSEcCtD
Thioridazine—Nausea—Ethinyl Estradiol—prostate cancer	0.000116	0.000853	CcSEcCtD
Thioridazine—Tachycardia—Mitoxantrone—prostate cancer	0.000116	0.000852	CcSEcCtD
Thioridazine—Lethargy—Epirubicin—prostate cancer	0.000115	0.000845	CcSEcCtD
Thioridazine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000115	0.000843	CcSEcCtD
Thioridazine—Oedema peripheral—Docetaxel—prostate cancer	0.000114	0.000836	CcSEcCtD
Thioridazine—Somnolence—Estradiol—prostate cancer	0.000113	0.000832	CcSEcCtD
Thioridazine—Weight increased—Prednisone—prostate cancer	0.000113	0.000832	CcSEcCtD
Thioridazine—Anorexia—Mitoxantrone—prostate cancer	0.000113	0.000832	CcSEcCtD
Thioridazine—Anaemia—Etoposide—prostate cancer	0.000112	0.000822	CcSEcCtD
Thioridazine—Hypotension—Mitoxantrone—prostate cancer	0.000111	0.000815	CcSEcCtD
Thioridazine—Decreased appetite—Estradiol—prostate cancer	0.000111	0.000814	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.00011	0.000812	CcSEcCtD
Thioridazine—Oedema peripheral—Capecitabine—prostate cancer	0.00011	0.00081	CcSEcCtD
Thioridazine—Diarrhoea—Goserelin—prostate cancer	0.00011	0.000808	CcSEcCtD
Thioridazine—Constipation—Estradiol—prostate cancer	0.000109	0.000801	CcSEcCtD
Thioridazine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000109	0.000801	CcSEcCtD
Thioridazine—Leukopenia—Etoposide—prostate cancer	0.000108	0.000796	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—prostate cancer	0.000107	0.000787	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—prostate cancer	0.000106	0.000782	CcSEcCtD
Thioridazine—Somnolence—Mitoxantrone—prostate cancer	0.000105	0.000776	CcSEcCtD
Thioridazine—Feeling abnormal—Estradiol—prostate cancer	0.000105	0.000772	CcSEcCtD
Thioridazine—Decreased appetite—Mitoxantrone—prostate cancer	0.000103	0.000758	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—prostate cancer	0.000103	0.000758	CcSEcCtD
Thioridazine—Vomiting—Goserelin—prostate cancer	0.000102	0.000751	CcSEcCtD
Thioridazine—Constipation—Mitoxantrone—prostate cancer	0.000101	0.000746	CcSEcCtD
Thioridazine—Rash—Goserelin—prostate cancer	0.000101	0.000745	CcSEcCtD
Thioridazine—Dermatitis—Goserelin—prostate cancer	0.000101	0.000744	CcSEcCtD
Thioridazine—Vomiting—Conjugated Estrogens—prostate cancer	0.000101	0.000744	CcSEcCtD
Thioridazine—Mental disorder—Docetaxel—prostate cancer	0.000101	0.000744	CcSEcCtD
Thioridazine—Body temperature increased—Estradiol—prostate cancer	0.000101	0.00074	CcSEcCtD
Thioridazine—Headache—Goserelin—prostate cancer	0.000101	0.00074	CcSEcCtD
Thioridazine—Erythema—Docetaxel—prostate cancer	0.0001	0.000739	CcSEcCtD
Thioridazine—Rash—Conjugated Estrogens—prostate cancer	0.0001	0.000738	CcSEcCtD
Thioridazine—Dermatitis—Conjugated Estrogens—prostate cancer	0.0001	0.000737	CcSEcCtD
Thioridazine—Arrhythmia—Capecitabine—prostate cancer	9.98e-05	0.000734	CcSEcCtD
Thioridazine—Headache—Conjugated Estrogens—prostate cancer	9.96e-05	0.000733	CcSEcCtD
Thioridazine—Confusional state—Etoposide—prostate cancer	9.94e-05	0.000732	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—prostate cancer	9.9e-05	0.000728	CcSEcCtD
Thioridazine—Mental disorder—Capecitabine—prostate cancer	9.79e-05	0.00072	CcSEcCtD
Thioridazine—Feeling abnormal—Mitoxantrone—prostate cancer	9.77e-05	0.000719	CcSEcCtD
Thioridazine—Erythema—Capecitabine—prostate cancer	9.72e-05	0.000716	CcSEcCtD
Thioridazine—Asthma—Epirubicin—prostate cancer	9.72e-05	0.000715	CcSEcCtD
Thioridazine—Thrombocytopenia—Etoposide—prostate cancer	9.66e-05	0.000711	CcSEcCtD
Thioridazine—Tachycardia—Etoposide—prostate cancer	9.62e-05	0.000708	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—prostate cancer	9.62e-05	0.000708	CcSEcCtD
Thioridazine—Nausea—Goserelin—prostate cancer	9.53e-05	0.000702	CcSEcCtD
Thioridazine—Hyperhidrosis—Etoposide—prostate cancer	9.53e-05	0.000702	CcSEcCtD
Thioridazine—Nausea—Conjugated Estrogens—prostate cancer	9.44e-05	0.000695	CcSEcCtD
Thioridazine—Anorexia—Etoposide—prostate cancer	9.4e-05	0.000692	CcSEcCtD
Thioridazine—Hypersensitivity—Estradiol—prostate cancer	9.37e-05	0.00069	CcSEcCtD
Thioridazine—Body temperature increased—Mitoxantrone—prostate cancer	9.37e-05	0.00069	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—prostate cancer	9.28e-05	0.000683	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—prostate cancer	9.23e-05	0.000679	CcSEcCtD
Thioridazine—Hypotension—Etoposide—prostate cancer	9.22e-05	0.000678	CcSEcCtD
Thioridazine—Vision blurred—Capecitabine—prostate cancer	9.16e-05	0.000674	CcSEcCtD
Thioridazine—Tremor—Capecitabine—prostate cancer	9.11e-05	0.00067	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—prostate cancer	8.99e-05	0.000662	CcSEcCtD
Thioridazine—Leukopenia—Docetaxel—prostate cancer	8.99e-05	0.000662	CcSEcCtD
Thioridazine—Anaemia—Capecitabine—prostate cancer	8.99e-05	0.000661	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—prostate cancer	8.91e-05	0.000655	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—prostate cancer	8.89e-05	0.000654	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—prostate cancer	8.87e-05	0.000653	CcSEcCtD
Thioridazine—Alimemazine—CYP3A4—prostate cancer	8.86e-05	0.0336	CrCbGaD
Thioridazine—Weight increased—Epirubicin—prostate cancer	8.85e-05	0.000651	CcSEcCtD
Thioridazine—Somnolence—Etoposide—prostate cancer	8.77e-05	0.000645	CcSEcCtD
Thioridazine—Hypersensitivity—Mitoxantrone—prostate cancer	8.74e-05	0.000643	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—prostate cancer	8.72e-05	0.000641	CcSEcCtD
Thioridazine—Diarrhoea—Estradiol—prostate cancer	8.71e-05	0.000641	CcSEcCtD
Thioridazine—Leukopenia—Capecitabine—prostate cancer	8.7e-05	0.00064	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—prostate cancer	8.67e-05	0.000638	CcSEcCtD
Thioridazine—Erythema—Prednisone—prostate cancer	8.66e-05	0.000637	CcSEcCtD
Thioridazine—Decreased appetite—Etoposide—prostate cancer	8.57e-05	0.000631	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—prostate cancer	8.54e-05	0.000629	CcSEcCtD
Thioridazine—Pipotiazine—CYP2C19—prostate cancer	8.53e-05	0.0324	CrCbGaD
Thioridazine—Jaundice—Epirubicin—prostate cancer	8.45e-05	0.000622	CcSEcCtD
Thioridazine—Constipation—Etoposide—prostate cancer	8.43e-05	0.000621	CcSEcCtD
Thioridazine—Chlorpromazine—SLC22A1—prostate cancer	8.43e-05	0.032	CrCbGaD
Thioridazine—Confusional state—Docetaxel—prostate cancer	8.26e-05	0.000608	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—prostate cancer	8.21e-05	0.000604	CcSEcCtD
Thioridazine—Oedema—Docetaxel—prostate cancer	8.2e-05	0.000603	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—prostate cancer	8.19e-05	0.000602	CcSEcCtD
Thioridazine—Vision blurred—Prednisone—prostate cancer	8.16e-05	0.000601	CcSEcCtD
Thioridazine—Feeling abnormal—Etoposide—prostate cancer	8.13e-05	0.000598	CcSEcCtD
Thioridazine—Diarrhoea—Mitoxantrone—prostate cancer	8.11e-05	0.000597	CcSEcCtD
Thioridazine—Vomiting—Estradiol—prostate cancer	8.09e-05	0.000595	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—prostate cancer	8.09e-05	0.000595	CcSEcCtD
Thioridazine—Eletriptan—CYP3A4—prostate cancer	8.05e-05	0.0306	CrCbGaD
Thioridazine—Thrombocytopenia—Docetaxel—prostate cancer	8.02e-05	0.000591	CcSEcCtD
Thioridazine—Rash—Estradiol—prostate cancer	8.02e-05	0.00059	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—prostate cancer	8.02e-05	0.00059	CcSEcCtD
Thioridazine—Dermatitis—Estradiol—prostate cancer	8.02e-05	0.00059	CcSEcCtD
Thioridazine—Anaemia—Prednisone—prostate cancer	8e-05	0.000589	CcSEcCtD
Thioridazine—Confusional state—Capecitabine—prostate cancer	8e-05	0.000589	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—prostate cancer	8e-05	0.000589	CcSEcCtD
Thioridazine—Headache—Estradiol—prostate cancer	7.97e-05	0.000587	CcSEcCtD
Thioridazine—Agitation—Prednisone—prostate cancer	7.96e-05	0.000586	CcSEcCtD
Thioridazine—Oedema—Capecitabine—prostate cancer	7.94e-05	0.000584	CcSEcCtD
Thioridazine—Angioedema—Prednisone—prostate cancer	7.91e-05	0.000582	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—prostate cancer	7.82e-05	0.000575	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—prostate cancer	7.81e-05	0.000575	CcSEcCtD
Thioridazine—Body temperature increased—Etoposide—prostate cancer	7.8e-05	0.000574	CcSEcCtD
Thioridazine—Thrombocytopenia—Capecitabine—prostate cancer	7.77e-05	0.000572	CcSEcCtD
Thioridazine—Tachycardia—Capecitabine—prostate cancer	7.74e-05	0.00057	CcSEcCtD
Thioridazine—Hyperhidrosis—Capecitabine—prostate cancer	7.67e-05	0.000565	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—prostate cancer	7.67e-05	0.000564	CcSEcCtD
Thioridazine—Hypotension—Docetaxel—prostate cancer	7.66e-05	0.000564	CcSEcCtD
Thioridazine—Mequitazine—CYP3A4—prostate cancer	7.63e-05	0.029	CrCbGaD
Thioridazine—Anorexia—Capecitabine—prostate cancer	7.56e-05	0.000557	CcSEcCtD
Thioridazine—Nausea—Estradiol—prostate cancer	7.56e-05	0.000556	CcSEcCtD
Thioridazine—Vomiting—Mitoxantrone—prostate cancer	7.54e-05	0.000555	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—prostate cancer	7.48e-05	0.000551	CcSEcCtD
Thioridazine—Rash—Mitoxantrone—prostate cancer	7.48e-05	0.00055	CcSEcCtD
Thioridazine—Dermatitis—Mitoxantrone—prostate cancer	7.47e-05	0.00055	CcSEcCtD
Thioridazine—Fluphenazine—CYP2E1—prostate cancer	7.45e-05	0.0283	CrCbGaD
Thioridazine—Headache—Mitoxantrone—prostate cancer	7.43e-05	0.000547	CcSEcCtD
Thioridazine—Hypotension—Capecitabine—prostate cancer	7.41e-05	0.000546	CcSEcCtD
Thioridazine—Somnolence—Docetaxel—prostate cancer	7.29e-05	0.000536	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—prostate cancer	7.27e-05	0.000535	CcSEcCtD
Thioridazine—Decreased appetite—Docetaxel—prostate cancer	7.12e-05	0.000524	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—prostate cancer	7.09e-05	0.000522	CcSEcCtD
Thioridazine—Oedema—Prednisone—prostate cancer	7.07e-05	0.00052	CcSEcCtD
Thioridazine—Nausea—Mitoxantrone—prostate cancer	7.04e-05	0.000518	CcSEcCtD
Thioridazine—Constipation—Docetaxel—prostate cancer	7.01e-05	0.000516	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—prostate cancer	6.95e-05	0.000512	CcSEcCtD
Thioridazine—Tachycardia—Prednisone—prostate cancer	6.9e-05	0.000508	CcSEcCtD
Thioridazine—Decreased appetite—Capecitabine—prostate cancer	6.9e-05	0.000508	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—prostate cancer	6.83e-05	0.000503	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—prostate cancer	6.82e-05	0.000502	CcSEcCtD
Thioridazine—Constipation—Capecitabine—prostate cancer	6.79e-05	0.000499	CcSEcCtD
Thioridazine—Erythema—Epirubicin—prostate cancer	6.77e-05	0.000498	CcSEcCtD
Thioridazine—Feeling abnormal—Docetaxel—prostate cancer	6.75e-05	0.000497	CcSEcCtD
Thioridazine—Diarrhoea—Etoposide—prostate cancer	6.75e-05	0.000497	CcSEcCtD
Thioridazine—Clomipramine—CYP2C19—prostate cancer	6.75e-05	0.0256	CrCbGaD
Thioridazine—Anorexia—Prednisone—prostate cancer	6.74e-05	0.000496	CcSEcCtD
Thioridazine—Feeling abnormal—Capecitabine—prostate cancer	6.54e-05	0.000481	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—prostate cancer	6.48e-05	0.000477	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—prostate cancer	6.43e-05	0.000473	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—prostate cancer	6.38e-05	0.00047	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—prostate cancer	6.31e-05	0.000464	CcSEcCtD
Thioridazine—Body temperature increased—Capecitabine—prostate cancer	6.27e-05	0.000462	CcSEcCtD
Thioridazine—Vomiting—Etoposide—prostate cancer	6.27e-05	0.000461	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—prostate cancer	6.27e-05	0.000461	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—prostate cancer	6.26e-05	0.000461	CcSEcCtD
Thioridazine—Agitation—Epirubicin—prostate cancer	6.22e-05	0.000458	CcSEcCtD
Thioridazine—Rash—Etoposide—prostate cancer	6.22e-05	0.000458	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—prostate cancer	6.21e-05	0.000457	CcSEcCtD
Thioridazine—Headache—Etoposide—prostate cancer	6.18e-05	0.000455	CcSEcCtD
Thioridazine—Decreased appetite—Prednisone—prostate cancer	6.14e-05	0.000452	CcSEcCtD
Thioridazine—Methotrimeprazine—CYP2E1—prostate cancer	6.13e-05	0.0233	CrCbGaD
Thioridazine—Leukopenia—Epirubicin—prostate cancer	6.06e-05	0.000446	CcSEcCtD
Thioridazine—Constipation—Prednisone—prostate cancer	6.04e-05	0.000445	CcSEcCtD
Thioridazine—Hypersensitivity—Docetaxel—prostate cancer	6.04e-05	0.000444	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—prostate cancer	5.91e-05	0.000435	CcSEcCtD
Thioridazine—Nausea—Etoposide—prostate cancer	5.86e-05	0.000431	CcSEcCtD
Thioridazine—Hypersensitivity—Capecitabine—prostate cancer	5.85e-05	0.00043	CcSEcCtD
Thioridazine—Perphenazine—CYP2C19—prostate cancer	5.83e-05	0.0221	CrCbGaD
Thioridazine—Feeling abnormal—Prednisone—prostate cancer	5.82e-05	0.000429	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—prostate cancer	5.79e-05	0.000426	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—prostate cancer	5.76e-05	0.000424	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—prostate cancer	5.61e-05	0.000413	CcSEcCtD
Thioridazine—Diarrhoea—Docetaxel—prostate cancer	5.61e-05	0.000413	CcSEcCtD
Thioridazine—Body temperature increased—Prednisone—prostate cancer	5.59e-05	0.000411	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—prostate cancer	5.57e-05	0.00041	CcSEcCtD
Thioridazine—Oedema—Epirubicin—prostate cancer	5.53e-05	0.000407	CcSEcCtD
Thioridazine—Diarrhoea—Capecitabine—prostate cancer	5.43e-05	0.0004	CcSEcCtD
Thioridazine—Pipotiazine—CYP3A4—prostate cancer	5.43e-05	0.0206	CrCbGaD
Thioridazine—Thrombocytopenia—Epirubicin—prostate cancer	5.41e-05	0.000398	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—prostate cancer	5.4e-05	0.000397	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—prostate cancer	5.34e-05	0.000393	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—prostate cancer	5.27e-05	0.000388	CcSEcCtD
Thioridazine—Promazine—CYP2C19—prostate cancer	5.26e-05	0.02	CrCbGaD
Thioridazine—Vomiting—Docetaxel—prostate cancer	5.21e-05	0.000383	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisone—prostate cancer	5.21e-05	0.000383	CcSEcCtD
Thioridazine—Prochlorperazine—CYP3A4—prostate cancer	5.19e-05	0.0197	CrCbGaD
Thioridazine—Rash—Docetaxel—prostate cancer	5.17e-05	0.00038	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—prostate cancer	5.17e-05	0.00038	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—prostate cancer	5.16e-05	0.00038	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—prostate cancer	5.16e-05	0.00038	CcSEcCtD
Thioridazine—Headache—Docetaxel—prostate cancer	5.13e-05	0.000378	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—prostate cancer	5.11e-05	0.000376	CcSEcCtD
Thioridazine—Vomiting—Capecitabine—prostate cancer	5.05e-05	0.000371	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—prostate cancer	5.01e-05	0.000369	CcSEcCtD
Thioridazine—Rash—Capecitabine—prostate cancer	5e-05	0.000368	CcSEcCtD
Thioridazine—Dermatitis—Capecitabine—prostate cancer	5e-05	0.000368	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—prostate cancer	4.99e-05	0.000367	CcSEcCtD
Thioridazine—Headache—Capecitabine—prostate cancer	4.97e-05	0.000366	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—prostate cancer	4.94e-05	0.000364	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—prostate cancer	4.91e-05	0.000362	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—prostate cancer	4.88e-05	0.000359	CcSEcCtD
Thioridazine—Nausea—Docetaxel—prostate cancer	4.87e-05	0.000358	CcSEcCtD
Thioridazine—Diarrhoea—Prednisone—prostate cancer	4.84e-05	0.000356	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—prostate cancer	4.81e-05	0.000354	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—prostate cancer	4.78e-05	0.000352	CcSEcCtD
Thioridazine—Constipation—Epirubicin—prostate cancer	4.73e-05	0.000348	CcSEcCtD
Thioridazine—Nausea—Capecitabine—prostate cancer	4.71e-05	0.000347	CcSEcCtD
Thioridazine—Chlorpromazine—CYP2E1—prostate cancer	4.67e-05	0.0177	CrCbGaD
Thioridazine—Feeling abnormal—Epirubicin—prostate cancer	4.56e-05	0.000335	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—prostate cancer	4.55e-05	0.000335	CcSEcCtD
Thioridazine—Vomiting—Prednisone—prostate cancer	4.49e-05	0.000331	CcSEcCtD
Thioridazine—Rash—Prednisone—prostate cancer	4.46e-05	0.000328	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—prostate cancer	4.45e-05	0.000328	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—prostate cancer	4.45e-05	0.000327	CcSEcCtD
Thioridazine—Headache—Prednisone—prostate cancer	4.43e-05	0.000326	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—prostate cancer	4.37e-05	0.000322	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—prostate cancer	4.37e-05	0.000322	CcSEcCtD
Thioridazine—Clomipramine—CYP3A4—prostate cancer	4.29e-05	0.0163	CrCbGaD
Thioridazine—Feeling abnormal—Doxorubicin—prostate cancer	4.22e-05	0.00031	CcSEcCtD
Thioridazine—Nausea—Prednisone—prostate cancer	4.2e-05	0.000309	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—prostate cancer	4.07e-05	0.0003	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—prostate cancer	4.04e-05	0.000298	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—prostate cancer	3.78e-05	0.000278	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—prostate cancer	3.77e-05	0.000277	CcSEcCtD
Thioridazine—Perphenazine—CYP3A4—prostate cancer	3.71e-05	0.0141	CrCbGaD
Thioridazine—Vomiting—Epirubicin—prostate cancer	3.51e-05	0.000259	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—prostate cancer	3.5e-05	0.000258	CcSEcCtD
Thioridazine—Rash—Epirubicin—prostate cancer	3.49e-05	0.000257	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—prostate cancer	3.48e-05	0.000256	CcSEcCtD
Thioridazine—Headache—Epirubicin—prostate cancer	3.46e-05	0.000255	CcSEcCtD
Thioridazine—Promazine—CYP3A4—prostate cancer	3.34e-05	0.0127	CrCbGaD
Thioridazine—Nausea—Epirubicin—prostate cancer	3.28e-05	0.000242	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—prostate cancer	3.25e-05	0.000239	CcSEcCtD
Thioridazine—Rash—Doxorubicin—prostate cancer	3.23e-05	0.000237	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—prostate cancer	3.22e-05	0.000237	CcSEcCtD
Thioridazine—Headache—Doxorubicin—prostate cancer	3.2e-05	0.000236	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—prostate cancer	3.04e-05	0.000224	CcSEcCtD
Thioridazine—Chlorpromazine—CYP3A4—prostate cancer	2.94e-05	0.0112	CrCbGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.53e-06	1.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	1.53e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTEN—prostate cancer	1.53e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—NOS3—prostate cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.52e-06	1.32e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—prostate cancer	1.52e-06	1.32e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—prostate cancer	1.52e-06	1.32e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.52e-06	1.32e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—prostate cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SRC—prostate cancer	1.51e-06	1.31e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SRC—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—prostate cancer	1.5e-06	1.3e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARA—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	1.47e-06	1.28e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.47e-06	1.28e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—prostate cancer	1.46e-06	1.28e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.46e-06	1.28e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.46e-06	1.28e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.46e-06	1.27e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	1.46e-06	1.27e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.46e-06	1.27e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—EP300—prostate cancer	1.46e-06	1.27e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—prostate cancer	1.45e-06	1.27e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.45e-06	1.27e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—prostate cancer	1.45e-06	1.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.45e-06	1.27e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—prostate cancer	1.45e-06	1.27e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—prostate cancer	1.45e-06	1.26e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	1.44e-06	1.26e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.44e-06	1.25e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.44e-06	1.25e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.43e-06	1.25e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—prostate cancer	1.43e-06	1.25e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.43e-06	1.25e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.43e-06	1.25e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—prostate cancer	1.43e-06	1.24e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—INS—prostate cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—INS—prostate cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAV1—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.39e-06	1.22e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.39e-06	1.21e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.39e-06	1.21e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.39e-06	1.21e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.39e-06	1.21e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.38e-06	1.21e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.38e-06	1.21e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.38e-06	1.2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.38e-06	1.2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.38e-06	1.2e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.38e-06	1.2e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.37e-06	1.2e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.37e-06	1.2e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—prostate cancer	1.37e-06	1.2e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—prostate cancer	1.37e-06	1.19e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.37e-06	1.19e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.37e-06	1.19e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EP300—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.36e-06	1.18e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—prostate cancer	1.36e-06	1.18e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.35e-06	1.18e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—prostate cancer	1.35e-06	1.18e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.35e-06	1.17e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EP300—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—EP300—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EP300—prostate cancer	1.34e-06	1.16e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.34e-06	1.16e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	1.33e-06	1.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.32e-06	1.15e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SRC—prostate cancer	1.32e-06	1.15e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.32e-06	1.15e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.32e-06	1.15e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.31e-06	1.15e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.31e-06	1.15e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.31e-06	1.14e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.31e-06	1.14e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.31e-06	1.14e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SRC—prostate cancer	1.3e-06	1.14e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SRC—prostate cancer	1.3e-06	1.13e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—prostate cancer	1.29e-06	1.12e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.29e-06	1.12e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.29e-06	1.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.28e-06	1.12e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.28e-06	1.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.28e-06	1.12e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.28e-06	1.11e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.28e-06	1.11e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.28e-06	1.11e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.27e-06	1.11e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.27e-06	1.11e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.27e-06	1.11e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.26e-06	1.1e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—prostate cancer	1.26e-06	1.1e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—prostate cancer	1.26e-06	1.1e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.26e-06	1.1e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.26e-06	1.09e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—prostate cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.24e-06	1.09e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.24e-06	1.08e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.24e-06	1.08e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.24e-06	1.08e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—prostate cancer	1.24e-06	1.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.23e-06	1.07e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.23e-06	1.07e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.22e-06	1.06e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—prostate cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—INS—prostate cancer	1.2e-06	1.05e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.19e-06	1.04e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—prostate cancer	1.19e-06	1.03e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—prostate cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—prostate cancer	1.17e-06	1.02e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—prostate cancer	1.16e-06	1.02e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—EP300—prostate cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.15e-06	1.01e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.15e-06	1e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.15e-06	1e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.15e-06	9.99e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.14e-06	9.96e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.14e-06	9.96e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.14e-06	9.96e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.14e-06	9.96e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.14e-06	9.95e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.14e-06	9.95e-06	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.14e-06	9.94e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.14e-06	9.94e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.14e-06	9.93e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.13e-06	9.87e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.12e-06	9.77e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.12e-06	9.76e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.12e-06	9.74e-06	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—prostate cancer	1.11e-06	9.67e-06	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—prostate cancer	1.1e-06	9.62e-06	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.1e-06	9.55e-06	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	1.09e-06	9.52e-06	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—prostate cancer	1.09e-06	9.5e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—prostate cancer	1.08e-06	9.44e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.08e-06	9.4e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.08e-06	9.4e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.08e-06	9.38e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.06e-06	9.25e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.06e-06	9.23e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.06e-06	9.23e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—prostate cancer	1.06e-06	9.22e-06	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—prostate cancer	1.06e-06	9.21e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.06e-06	9.2e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.04e-06	9.05e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—EP300—prostate cancer	1.03e-06	9e-06	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—prostate cancer	1.01e-06	8.85e-06	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—prostate cancer	1.01e-06	8.81e-06	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.01e-06	8.78e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—prostate cancer	9.95e-07	8.68e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	9.9e-07	8.64e-06	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—prostate cancer	9.89e-07	8.63e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	9.88e-07	8.62e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—prostate cancer	9.86e-07	8.6e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	9.8e-07	8.55e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—prostate cancer	9.75e-07	8.51e-06	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—prostate cancer	9.73e-07	8.49e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	9.72e-07	8.48e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	9.69e-07	8.46e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—prostate cancer	9.66e-07	8.43e-06	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—prostate cancer	9.66e-07	8.43e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—prostate cancer	9.58e-07	8.35e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—prostate cancer	9.56e-07	8.34e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—EP300—prostate cancer	9.49e-07	8.28e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—EP300—prostate cancer	9.41e-07	8.2e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—prostate cancer	9.4e-07	8.2e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—prostate cancer	9.38e-07	8.18e-06	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—prostate cancer	9.36e-07	8.17e-06	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—prostate cancer	9.31e-07	8.12e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	9.01e-07	7.86e-06	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	8.92e-07	7.78e-06	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—prostate cancer	8.91e-07	7.77e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—prostate cancer	8.8e-07	7.68e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—prostate cancer	8.77e-07	7.65e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—prostate cancer	8.75e-07	7.63e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—prostate cancer	8.71e-07	7.6e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—prostate cancer	8.61e-07	7.51e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—prostate cancer	8.58e-07	7.49e-06	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.55e-07	7.46e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—prostate cancer	8.43e-07	7.35e-06	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—prostate cancer	8.22e-07	7.17e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—prostate cancer	8.09e-07	7.05e-06	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—prostate cancer	8.08e-07	7.05e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—prostate cancer	8.07e-07	7.04e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—EP300—prostate cancer	8.04e-07	7.01e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—prostate cancer	7.98e-07	6.96e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—prostate cancer	7.94e-07	6.93e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	7.92e-07	6.91e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.63e-07	6.66e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	7.36e-07	6.42e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.02e-07	6.12e-06	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—prostate cancer	6.98e-07	6.09e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.96e-07	6.07e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—prostate cancer	6.23e-07	5.44e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.95e-07	5.19e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—prostate cancer	5.73e-07	5e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—prostate cancer	5.68e-07	4.96e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—prostate cancer	4.86e-07	4.24e-06	CbGpPWpGaD
